Zoetis (ZTS) |
United States |
$77.646B |
42.46 |
Takeda Pharmaceutical (TAK) |
Japan |
$53.647B |
9.83 |
Astellas Pharma (ALPMY) |
Japan |
$28.188B |
17.40 |
Eisai (ESALY) |
Japan |
$19.710B |
21.86 |
Catalent (CTLT) |
United States |
$18.562B |
49.12 |
Grifols, S.A (GRFS) |
Spain |
$12.273B |
14.28 |
Jazz Pharmaceuticals (JAZZ) |
Ireland |
$9.199B |
15.36 |
United Therapeutics (UTHR) |
United States |
$8.878B |
17.24 |
Neurocrine Biosciences (NBIX) |
United States |
$8.789B |
20.25 |
Hikma Pharmaceuticals Plc (HKMPF) |
United Kingdom |
$7.997B |
0.00 |
IPSEN SA ADR (IPSEY) |
France |
$7.479B |
0.00 |
Arrowhead Pharmaceuticals (ARWR) |
United States |
$6.635B |
0.00 |
Evotec AG (EVTCY) |
Germany |
$6.555B |
442.61 |
Orion OYJ (ORINY) |
Finland |
$5.789B |
20.11 |
Ionis Pharmaceuticals (IONS) |
United States |
$5.788B |
0.00 |
Sage Therapeutics (SAGE) |
United States |
$4.200B |
0.00 |
Hypermarcas (HYPMY) |
Brazil |
$3.984B |
15.73 |
Turning Point Therapeutics (TPTX) |
United States |
$3.664B |
0.00 |
Nektar Therapeutics (NKTR) |
United States |
$3.407B |
0.00 |
PTC Therapeutics (PTCT) |
United States |
$3.327B |
0.00 |
ChemoCentryx (CCXI) |
United States |
$3.290B |
0.00 |
Tilray (TLRY) |
Canada |
$3.147B |
0.00 |
Cronos Group (CRON) |
Canada |
$3.030B |
0.00 |
Pacira BioSciences (PCRX) |
United States |
$2.994B |
50.56 |
Relay Therapeutics (RLAY) |
United States |
$2.890B |
0.00 |
Taro Pharmaceutical Industries (TARO) |
Israel |
$2.770B |
17.15 |
Revolution Medicines (RVMD) |
United States |
$2.758B |
0.00 |
Organogenesis Holdings (ORGO) |
United States |
$2.700B |
162.31 |
Corcept Therapeutics (CORT) |
United States |
$2.614B |
26.21 |
Xencor (XNCR) |
United States |
$2.330B |
0.00 |
USANA Health Sciences (USNA) |
United States |
$2.069B |
17.12 |
FibroGen (FGEN) |
United States |
$1.806B |
0.00 |
AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$1.727B |
11.08 |
BioCryst Pharmaceuticals (BCRX) |
United States |
$1.719B |
0.00 |
Ironwood Pharmaceuticals (IRWD) |
United States |
$1.660B |
13.05 |
Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$1.630B |
0.00 |
Sundial Growers (SNDL) |
Canada |
$1.627B |
0.00 |
AlloVir (ALVR) |
United States |
$1.541B |
0.00 |
Heron Therapeutics (HRTX) |
United States |
$1.523B |
0.00 |
ImmunoGen (IMGN) |
United States |
$1.452B |
0.00 |
Endo (ENDP) |
Ireland |
$1.408B |
2.13 |
Aclaris Therapeutics (ACRS) |
United States |
$1.371B |
0.00 |
Theravance Biopharma (TBPH) |
Cayman Islands |
$1.342B |
0.00 |
Indivior (INVVY) |
United States |
$1.333B |
0.00 |
Translate Bio (TBIO) |
United States |
$1.310B |
0.00 |
Ocular Therapeutix (OCUL) |
United States |
$1.209B |
0.00 |
Zogenix (ZGNX) |
United States |
$1.064B |
0.00 |
Trillium Therapeutics (TRIL) |
Canada |
$1.038B |
0.00 |
Enanta Pharmaceuticals (ENTA) |
United States |
$0.997B |
0.00 |
4D Molecular Therapeutics (FDMT) |
|
$0.954B |
0.00 |
CLINIGEN GP (CLIGF) |
United Kingdom |
$0.942B |
0.00 |
Radius Health (RDUS) |
United States |
$0.886B |
0.00 |
Aerie Pharmaceuticals (AERI) |
United States |
$0.875B |
0.00 |
Vectura Group (VEGPF) |
United Kingdom |
$0.864B |
0.00 |
Bioventus (BVS) |
United States |
$0.814B |
0.00 |
Collegium Pharmaceutical (COLL) |
United States |
$0.807B |
30.15 |
Karyopharm Therapeutics (KPTI) |
United States |
$0.758B |
0.00 |
Esperion Therapeutics (ESPR) |
United States |
$0.732B |
0.00 |
Ardelyx (ARDX) |
United States |
$0.711B |
0.00 |
Silence Therapeutics (SLN) |
United Kingdom |
$0.689B |
0.00 |
Rafael Holdings (RFL) |
United States |
$0.672B |
0.00 |
Calliditas Therapeutics AB (CALT) |
Sweden |
$0.667B |
0.00 |
VAXART, INC (VXRT) |
United States |
$0.650B |
0.00 |
Harpoon Therapeutics (HARP) |
United States |
$0.644B |
0.00 |
KalVista Pharmaceuticals (KALV) |
United States |
$0.636B |
0.00 |
Rigel Pharmaceuticals (RIGL) |
United States |
$0.614B |
0.00 |
Chinook Therapeutics (KDNY) |
United States |
$0.589B |
0.00 |
Sigilon Therapeutics (SGTX) |
|
$0.587B |
0.00 |
Siga Technologies (SIGA) |
United States |
$0.540B |
9.01 |
Nanobiotix S.A (NBTX) |
France |
$0.539B |
0.00 |
Crinetics Pharmaceuticals (CRNX) |
United States |
$0.529B |
0.00 |
Marinus Pharmaceuticals (MRNS) |
United States |
$0.518B |
0.00 |
Avadel Pharmaceuticals (AVDL) |
Ireland |
$0.499B |
0.00 |
TherapeuticsMD (TXMD) |
United States |
$0.495B |
0.00 |
Altimmune (ALT) |
United States |
$0.471B |
0.00 |
Flexion Therapeutics (FLXN) |
United States |
$0.469B |
0.00 |
Akebia Therapeutics (AKBA) |
United States |
$0.465B |
0.00 |
Spectrum Pharmaceuticals (SPPI) |
United States |
$0.456B |
0.00 |
Catalyst Pharmaceuticals (CPRX) |
United States |
$0.455B |
10.68 |
Foghorn Therapeutics (FHTX) |
United States |
$0.450B |
0.00 |
AVITA Medical (RCEL) |
United States |
$0.449B |
0.00 |
Summit Therapeutics (SMMT) |
United States |
$0.446B |
0.00 |
Molecular Templates (MTEM) |
United States |
$0.441B |
0.00 |
Jounce Therapeutics (JNCE) |
United States |
$0.420B |
0.00 |
PROFOUND MEDICL (PROF) |
Canada |
$0.415B |
0.00 |
MEI Pharma (MEIP) |
United States |
$0.399B |
0.00 |
DURECT (DRRX) |
United States |
$0.398B |
0.00 |
Nature's Sunshine Products (NATR) |
United States |
$0.387B |
18.44 |
Acutus Medical (AFIB) |
United States |
$0.370B |
0.00 |
Innate Pharma SA (IPHYF) |
France |
$0.347B |
0.00 |
Redhill Biopharma (RDHL) |
Israel |
$0.332B |
0.00 |
Oncternal Therapeutics (ONCT) |
United States |
$0.317B |
0.00 |
Clever Leaves Holdings (CLVR) |
United States |
$0.311B |
0.00 |
VYNE Therapeutics (VYNE) |
United States |
$0.289B |
0.00 |
Infinity Pharmaceuticals (INFI) |
United States |
$0.269B |
0.00 |
CASI Pharmaceuticals (CASI) |
United States |
$0.266B |
0.00 |
Taiwan Liposome (TLC) |
Taiwan |
$0.250B |
0.00 |
Alpine Immune Sciences (ALPN) |
United States |
$0.250B |
0.00 |
KemPharm (KMPH) |
United States |
$0.245B |
0.00 |
Xeris Pharmaceuticals (XERS) |
United States |
$0.237B |
0.00 |
Inotiv (NOTV) |
United States |
$0.233B |
0.00 |
Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.226B |
0.00 |
Iterum Therapeutics (ITRM) |
Ireland |
$0.224B |
0.00 |
Jaguar Animal Health (JAGX) |
United States |
$0.220B |
0.00 |
Dipexium Pharmaceuticals (PLXP) |
United States |
$0.218B |
0.00 |
Progenity (PROG) |
United States |
$0.212B |
0.00 |
Sierra Oncology (SRRA) |
Canada |
$0.210B |
0.00 |
Novan (NOVN) |
United States |
$0.202B |
0.00 |
Lannett Co Inc (LCI) |
United States |
$0.201B |
6.75 |
Oasmia Pharmaceutical AB (OASMY) |
Sweden |
$0.200B |
0.00 |
Matinas Biopharma Holdings (MTNB) |
United States |
$0.198B |
0.00 |
OptiNose (OPTN) |
United States |
$0.187B |
0.00 |
CTI BioPharma (CTIC) |
United States |
$0.185B |
0.00 |
IMV INC (IMV) |
Canada |
$0.185B |
0.00 |
Heat Biologics (HTBX) |
United States |
$0.170B |
0.00 |
MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.166B |
0.00 |
Adherex Technologies (FENC) |
United States |
$0.164B |
0.00 |
Calithera Biosciences (CALA) |
United States |
$0.159B |
0.00 |
SCYNEXIS (SCYX) |
United States |
$0.159B |
0.00 |
Onconova Therapeutics (ONTX) |
United States |
$0.159B |
0.00 |
Vivos Therapeutics (VVOS) |
|
$0.158B |
0.00 |
Qilian Holding Group (QLI) |
China |
$0.156B |
0.00 |
AcelRx Pharmaceuticals (ACRX) |
United States |
$0.156B |
0.00 |
Champions Oncology (CSBR) |
United States |
$0.153B |
0.00 |
Aquestive Therapeutics (AQST) |
United States |
$0.150B |
0.00 |
Concert Pharmaceuticals (CNCE) |
United States |
$0.149B |
0.00 |
IsoRay (ISR) |
United States |
$0.147B |
0.00 |
MediWound (MDWD) |
Israel |
$0.139B |
0.00 |
Ayala Pharmaceuticals (AYLA) |
Israel |
$0.138B |
0.00 |
Aziyo Biologics (AZYO) |
United States |
$0.134B |
0.00 |
Nutriband (NTRB) |
United States |
$0.133B |
0.00 |
Lipocine (LPCN) |
United States |
$0.131B |
0.00 |
GlycoMimetics (GLYC) |
United States |
$0.130B |
0.00 |
Genocea Biosciences (GNCA) |
United States |
$0.123B |
0.00 |
PolarityTE (PTE) |
United States |
$0.117B |
0.00 |
La Jolla Pharmaceutical (LJPC) |
United States |
$0.110B |
0.00 |
Adamis Pharmaceuticals (ADMP) |
United States |
$0.109B |
0.00 |
Natural Alternatives (NAII) |
United States |
$0.107B |
29.14 |
Otonomy (OTIC) |
United States |
$0.105B |
0.00 |
Minerva Neurosciences (NERV) |
United States |
$0.103B |
40.33 |
AIM ImmunoTech (AIM) |
United States |
$0.103B |
0.00 |
Savara (SVRA) |
United States |
$0.098B |
0.00 |
Aptorum Group (APM) |
Hong Kong, SAR China |
$0.095B |
0.00 |
Recro Pharma (REPH) |
United States |
$0.091B |
0.00 |
Assertio Holdings (ASRT) |
United States |
$0.090B |
0.00 |
ElectroCore (ECOR) |
United States |
$0.089B |
0.00 |
Regulus Therapeutics (RGLS) |
United States |
$0.086B |
0.00 |
Galmed Pharmaceuticals (GLMD) |
Israel |
$0.080B |
0.00 |
ProPhase Labs (PRPH) |
United States |
$0.077B |
0.00 |
Baudax Bio (BXRX) |
United States |
$0.077B |
0.00 |
India Globalization Capital (IGC) |
United States |
$0.073B |
0.00 |
Entasis Therapeutics Holdings (ETTX) |
United States |
$0.072B |
0.00 |
Addex Therapeutics (ADXN) |
Switzerland |
$0.069B |
0.00 |
Trimel Pharmaceuticals (ASPCF) |
Canada |
$0.063B |
0.00 |
RENEURON GP (RNUGF) |
United Kingdom |
$0.062B |
0.00 |
Sigyn Therapeutics (SIGY) |
United States |
$0.062B |
0.00 |
Brickell Biotech (BBI) |
United States |
$0.061B |
0.00 |
AgeX Therapeutics (AGE) |
United States |
$0.060B |
0.00 |
Biomerica (BMRA) |
United States |
$0.058B |
0.00 |
IntelGenx Technologies (IGXT) |
Canada |
$0.058B |
0.00 |
Salarius Pharmaceuticals (SLRX) |
United States |
$0.057B |
0.00 |
Inhibikase Therapeutics (IKT) |
United States |
$0.055B |
0.00 |
HANCOCK JAFFE (HJLI) |
United States |
$0.054B |
0.00 |
CV Sciences (CVSI) |
United States |
$0.052B |
0.00 |
Opiant Pharmaceuticals (OPNT) |
United States |
$0.048B |
0.00 |
Cumberland Pharmaceuticals (CPIX) |
United States |
$0.047B |
62.40 |
Viracta Therapeutics (VIRX) |
United States |
$0.041B |
0.00 |
Mannatech (MTEX) |
United States |
$0.040B |
7.12 |
Can-Fite Biopharma (CANF) |
Israel |
$0.039B |
0.00 |
NovaBay Pharmaceuticals (NBY) |
United States |
$0.034B |
0.00 |
4D Pharma (LBPS) |
United Kingdom |
$0.033B |
0.00 |
RXi Pharmaceuticals (PHIO) |
United States |
$0.032B |
0.00 |
Petros Pharmaceuticals (PTPI) |
United States |
$0.031B |
0.00 |
Eyegate Pharmaceuticals (EYEG) |
United States |
$0.031B |
0.00 |
Bellicum Pharmaceuticals (BLCM) |
United States |
$0.028B |
0.00 |
China SXT Pharmaceuticals (SXTC) |
China |
$0.022B |
0.00 |
JanOne (JAN) |
United States |
$0.021B |
0.00 |
Plus Therapeutics (PSTV) |
United States |
$0.020B |
0.00 |
Cyanotech (CYAN) |
United States |
$0.019B |
15.75 |
Xenetic Biosciences (XBIO) |
United States |
$0.019B |
0.00 |
SHINECO INC (TYHT) |
China |
$0.017B |
0.00 |
Sonoma Pharmaceuticals (SNOA) |
United States |
$0.017B |
0.00 |
CannTrust Holdings (CTST) |
Canada |
$0.000B |
0.00 |